27 Mar 2018
ICLR 2018
Authors: Daniel Neil, Marwin Segler, Laura Guasch, Mohamed Ahmed, Dean Plumbley, Matthew Sellwood, Nathan Brown
Abstract
The essence of molecular design is to effectively fulfill a molecular property profile that is desirable as a drug. In this paper we consider a number of different generative models for the design of new molecular structures the satisfy specific multiple objectives that are desirable for a particular drug discovery project. In addition to the evaluation of multiple generative models, we also presented as part of this work a benchmarking dataset to the community with the aim to provide an objective set to evaluate other new de novo molecular design models appropriately
Back to publications
Latest publications
01 May 2024
Journal of Biomedical Semantics, volume 15, Article number: 5 (2024) Elucidating the Semantics-Topology Trade-off for Knowledge Inference-Based Pharmacological Discovery
Read more
12 Oct 2023
Translational Neurodegeneration. 2023; 12: 47 Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
Read more
09 Oct 2023
FRONTIERS IN GENETICS Learning the kernel for rare variant genetic association test
Read more